* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Download CHLORTETRACYCLINE
Survey
Document related concepts
Transcript
CHLORTETRACYCLINE CLINICAL APPLICATIONS THERAPEUTIC USES C. CHLAMYDIAL INFECTIONS 1. OVERVIEW: FDA APPROVAL: Adult, no; pediatric, no EFFICACY: Adult, possibly effective; pediatric, possibly effective DOCUMENTATION: Adult, fair; pediatric, fair 2. SUMMARY: - Chlortetracycline alone or in combination therapy has been effective in treatment of chlamydial infections - Neonatal ocular chlamydial infection best treated with chlortetracycline/erythromycin combination - Controlled studies are lacking 3. ADULT: a. In an open study of 69 men with chlamydia-positive nonspecific or post-gonococcal urethritis, chlortetracycline 250 milligrams four times a day oral dose was administered for either 4 to 10 days or 12 to 18 days. The total number of resolved cases was 71%, with a better score for the long-term treatment (80%) than the short-term (59%) group. In four cases in the short-term group (14%), the relapse with re-isolation of C trachomatis was observed but without significant difference. The minimum inhibitory concentration (MIC) has ranged from 0.02 to 1 microgram per milliliter (Terho, 1978). b. In an open study, 75 chlamydia-positive women were treated with triple tetracycline combination: chlortetracycline hydrochloride 115.4 milligrams (mg) plus tetracycline hydrochloride 115.4 mg plus demeclocycline hydrochloride 69.2 mg (Deteclo(R) 300 mg) twice daily for 7 or 21 days. Chlamydia was eradicated from the female genital tract during both treatment periods (Waugh & Nayyar, 1977). c. For More Information: See Drug Consult reference: "CHLAMYDIAL INFECTIONS 1998 CDC GUIDELINES" See Drug Consult reference: "CHLAMYDIA-INDUCED URETHRITIS, CERVICITIS, CONJUNCTIVITIS, PROCTITIS DRUG OF CHOICE" See Drug Consult reference: "CHLAMYDIA TRACHOMATIS DRUG OF CHOICE" 4. PEDIATRIC: a. Neonatal ocular chlamydial infection can be adequately treated with chlortetracycline 1% eye ointment in association with systemic erythromycin (30 milligrams/kilogram/day) for 21 days. Since chlamydial ophthalmic neonatal infection is acquired during birth, both the mother and the father should be investigated and treated (Ridgway & Oriel, 1977). b. In a small study, chlortetracycline 1% eye ointment monotherapy was effective in only 3 of 6 infants; the infection in non-responders resolved with the addition of systemic erythromycin (40 milligrams (mg) per kilogram per day) for 2 weeks. No failures were observed in 4 adult patients treated with chlortetracycline 1% eye ointment plus erythromycin 500 mg twice daily for 2 weeks (Molgaard et al, 1983). c. For More Information: See Drug Consult reference: "CHLAMYDIA-INDUCED URETHRITIS, CERVICITIS, CONJUNCTIVITIS, PROCTITIS DRUG OF CHOICE